PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12804128-4	2003	Subjects had completed a pharmacokinetic study over 23 days, during which the dosage of quetiapine was increased sequentially from 25 mg bid to a maximum of 400 mg bid (800 mg/day) (McConville et al.	Quetiapine Fumarate	88-98	BH3 interacting domain death agonist	Homo sapiens	137-140	
17729385-9	2007	CONCLUSION: Combination therapy with quetiapine (150 mg bid) and divalproex (500 mg bid) resulted in small and statistically non-significant pharmacokinetic changes.	Quetiapine Fumarate	37-47	BH3 interacting domain death agonist	Homo sapiens	56-59	
17729385-9	2007	CONCLUSION: Combination therapy with quetiapine (150 mg bid) and divalproex (500 mg bid) resulted in small and statistically non-significant pharmacokinetic changes.	Quetiapine Fumarate	37-47	BH3 interacting domain death agonist	Homo sapiens	84-87